Puma Biotechnology Inc (PBYI)
5.02
+0.14
(+2.87%)
USD |
NASDAQ |
Apr 26, 16:00
5.03
+0.01
(+0.20%)
After-Hours: 20:00
Puma Biotechnology Research and Development Expense (Quarterly): 12.87M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 12.87M |
| September 30, 2023 | 11.45M |
| June 30, 2023 | 13.36M |
| March 31, 2023 | 12.71M |
| December 31, 2022 | 13.78M |
| September 30, 2022 | 11.25M |
| June 30, 2022 | 11.97M |
| March 31, 2022 | 15.24M |
| December 31, 2021 | 14.17M |
| September 30, 2021 | 18.84M |
| June 30, 2021 | 18.64M |
| March 31, 2021 | 20.23M |
| December 31, 2020 | 24.16M |
| September 30, 2020 | 23.34M |
| June 30, 2020 | 24.69M |
| March 31, 2020 | 25.46M |
| December 31, 2019 | 30.24M |
| September 30, 2019 | 30.03M |
| June 30, 2019 | 36.86M |
| March 31, 2019 | 35.73M |
| December 31, 2018 | 38.32M |
| September 30, 2018 | 36.36M |
| June 30, 2018 | 43.24M |
| March 31, 2018 | 46.92M |
| December 31, 2017 | 50.25M |
| Date | Value |
|---|---|
| September 30, 2017 | 49.50M |
| June 30, 2017 | 53.25M |
| March 31, 2017 | 54.80M |
| December 31, 2016 | 56.40M |
| September 30, 2016 | 51.98M |
| June 30, 2016 | 54.22M |
| March 31, 2016 | 60.21M |
| December 31, 2015 | 52.44M |
| September 30, 2015 | 51.92M |
| June 30, 2015 | 59.38M |
| March 31, 2015 | 44.73M |
| December 31, 2014 | 39.53M |
| September 30, 2014 | 32.09M |
| June 30, 2014 | 35.00M |
| March 31, 2014 | 16.29M |
| December 31, 2013 | 13.01M |
| September 30, 2013 | 12.07M |
| June 30, 2013 | 10.44M |
| March 31, 2013 | 9.532M |
| December 31, 2012 | 8.282M |
| September 30, 2012 | 17.78M |
| June 30, 2012 | 13.01M |
| March 31, 2012 | 10.57M |
| December 31, 2011 | 0.826M |
| September 30, 2011 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
11.25M
Minimum
Sep 2022
36.86M
Maximum
Jun 2019
19.44M
Average
18.64M
Median
Jun 2021
Research and Development Expense (Quarterly) Benchmarks
| ADMA Biologics Inc | 0.4455M |
| Pfizer Inc | 2.815B |
| Sarepta Therapeutics Inc | 195.52M |
| Immunogen Inc (DELISTED) | 47.57M |
| Regeneron Pharmaceuticals Inc | 1.177B |